HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

CHATTEM CONSUMER PRODUCTS U.S. REVENUES GAIN 1% IN FIRST HALF

This article was originally published in The Rose Sheet

Executive Summary

CHATTEM CONSUMER PRODUCTS U.S. REVENUES GAIN 1% IN FIRST HALF ended May 31, the firm announced June 24. The Chattanooga, TN- based company noted that the "sales increase was led by a solid performance from its OTC pharmaceuticals groups group," which posted a 12% sales increase in the six months and includes the Pamprin, Premsyn PMS, Flex-all 454 and Icy Hot brands. Norwich aspirin was the only OTC brand for which sales declined, Chattem said. The firm pointed to the improvement in OTC sales as "an early sign that inventory reductions at the retail level experienced during the last half of 1993 should be subsiding."

Latest Headlines
See All
UsernamePublicRestriction

Register

RS000606

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel